Drexel University College of Medicine, Philadelphia, PA, USA.
Department of Biobehavioral Health Sciences, University of Pennsylvania School of Nursing, 418 Curie Blvd, Philadelphia, PA, 19104, USA.
Obes Surg. 2021 Oct;31(10):4612-4623. doi: 10.1007/s11695-021-05585-6. Epub 2021 Aug 9.
This systematic review synthesized research evaluating the relationship between genetic predictors and weight loss after bariatric surgery. Fifty-seven studies were identified that examined single genes or genetic risk scores. Uncoupling protein (UCP) rs660339 was associated with excess weight loss after surgery in 4 of 6 studies. The most commonly assessed genes were fat mass and obesity-associated (FTO) gene (n = 10) and melanocortin-4 receptor (MC4R) (n = 14). Both were inconsistently related to weight loss. Genetic risk scores predicted weight loss in 6 of 7 studies. This evidence suggests the potential of using genetic variants and genetic risk scores to predict the amount of weight loss anticipated after bariatric surgery and identify patients who may be at risk for suboptimal weight reduction.
本系统综述综合了评估遗传预测因子与减重手术减肥效果之间关系的研究。共确定了 57 项研究,这些研究检查了单一基因或遗传风险评分。在 6 项研究中的 4 项研究中,解偶联蛋白(UCP)rs660339 与手术后超重减轻有关。评估最多的基因是脂肪量和肥胖相关(FTO)基因(n=10)和黑素皮质素 4 受体(MC4R)(n=14)。这两个基因与减肥效果均不一致。遗传风险评分在 7 项研究中的 6 项中预测了减肥效果。该证据表明,有可能使用遗传变异和遗传风险评分来预测减重手术后预期的减肥量,并识别可能存在减肥效果不理想风险的患者。